Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Persistent Impairment of T-Cell Regeneration in a Patient with Activated PI3K δ Syndrome.

Literature DB >> 28432485

Persistent Impairment of T-Cell Regeneration in a Patient with Activated PI3K δ Syndrome.

Fumihiro Goto¹, Toru Uchiyama², Yumiko Nakazawa¹, Kohsuke Imai³, Toshinao Kawai¹, Masafumi Onodera¹.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2017 PMID： 28432485 DOI： 10.1007/s10875-017-0393-7

Source DB: PubMed Journal: J Clin Immunol ISSN： 0271-9142 Impact factor: 8.317

× No keyword cloud information.

5 in total

1. Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome.

Authors: William Rae; Kesava A Ramakrishnan; Yifang Gao; Margaret Ashton-Key; Reuben J Pengelly; Sanjay V Patel; Sarah Ennis; Anthony P Williams; Saul N Faust
Journal: Clin Immunol Date: 2016-07-19 Impact factor: 3.969

2. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor.

Authors: Yann M Kerdiles; Daniel R Beisner; Roberto Tinoco; Anne S Dejean; Diego H Castrillon; Ronald A DePinho; Stephen M Hedrick
Journal: Nat Immunol Date: 2009-01-11 Impact factor: 25.606

3. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.

Authors: Carrie L Lucas; Hye Sun Kuehn; Fang Zhao; Julie E Niemela; Elissa K Deenick; Umaimainthan Palendira; Danielle T Avery; Leen Moens; Jennifer L Cannons; Matthew Biancalana; Jennifer Stoddard; Weiming Ouyang; David M Frucht; V Koneti Rao; T Prescott Atkinson; Anahita Agharahimi; Ashleigh A Hussey; Les R Folio; Kenneth N Olivier; Thomas A Fleisher; Stefania Pittaluga; Steven M Holland; Jeffrey I Cohen; Joao B Oliveira; Stuart G Tangye; Pamela L Schwartzberg; Michael J Lenardo; Gulbu Uzel
Journal: Nat Immunol Date: 2013-10-28 Impact factor: 25.606

Review 4. mTOR Links Environmental Signals to T Cell Fate Decisions.

Authors: Nicole M Chapman; Hongbo Chi
Journal: Front Immunol Date: 2015-01-20 Impact factor: 7.561

5. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage.

Authors: Ivan Angulo; Oscar Vadas; Fabien Garçon; Edward Banham-Hall; Vincent Plagnol; Timothy R Leahy; Helen Baxendale; Tanya Coulter; James Curtis; Changxin Wu; Katherine Blake-Palmer; Olga Perisic; Deborah Smyth; Mailis Maes; Christine Fiddler; Jatinder Juss; Deirdre Cilliers; Gašper Markelj; Anita Chandra; George Farmer; Anna Kielkowska; Jonathan Clark; Sven Kracker; Marianne Debré; Capucine Picard; Isabelle Pellier; Nada Jabado; James A Morris; Gabriela Barcenas-Morales; Alain Fischer; Len Stephens; Phillip Hawkins; Jeffrey C Barrett; Mario Abinun; Menna Clatworthy; Anne Durandy; Rainer Doffinger; Edwin R Chilvers; Andrew J Cant; Dinakantha Kumararatne; Klaus Okkenhaug; Roger L Williams; Alison Condliffe; Sergey Nejentsev
Journal: Science Date: 2013-10-17 Impact factor: 47.728

5 in total

6 in total

Persistent Impairment of T-Cell Regeneration in a Patient with Activated PI3K δ Syndrome.

1. Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome.

2. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor.

3. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.

Review 4. mTOR Links Environmental Signals to T Cell Fate Decisions.

5. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage.

Review 1. Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD-the Goldilocks' Effect.

2. Control of CD4⁺ T Cell Differentiation and Function by PI3K Isoforms.

Review 3. Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome.

Review 4. Bacille Calmette-Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010-2017.

Review 5. Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.

Review 6. Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.

Persistent Impairment of T-Cell Regeneration in a Patient with Activated PI3K δ Syndrome.

1. Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome.

2. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor.

3. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.

Review 4. mTOR Links Environmental Signals to T Cell Fate Decisions.

5. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage.

Review 1. Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD-the Goldilocks' Effect.

2. Control of CD4+ T Cell Differentiation and Function by PI3K Isoforms.

Review 3. Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome.

Review 4. Bacille Calmette-Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010-2017.

Review 5. Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.

Review 6. Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.

2. Control of CD4⁺ T Cell Differentiation and Function by PI3K Isoforms.